Literature DB >> 22383493

When GLP-1 hits the liver: a novel approach for insulin resistance and NASH.

Yong Ook Kim, Detlef Schuppan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22383493     DOI： 10.1152/ajpgi.00078.2012

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN： 0193-1857            Impact factor:   4.052


× No keyword cloud information.
  11 in total

1.  Liraglutide attenuates partial warm ischemia-reperfusion injury in rat livers.

Authors:  Ahmed A Abdelsameea; Noha A T Abbas; Samar M Abdel Raouf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-16       Impact factor: 3.000

2.  Resistant maltodextrin or fructooligosaccharides promotes GLP-1 production in male rats fed a high-fat and high-sucrose diet, and partially reduces energy intake and adiposity.

Authors:  Tohru Hira; Ryoya Suto; Yuka Kishimoto; Sumiko Kanahori; Hiroshi Hara
Journal:  Eur J Nutr       Date:  2017-02-04       Impact factor: 5.614

3.  Pharmacological agents for nonalcoholic steatohepatitis.

Authors:  Maeva Guillaume; Vlad Ratziu
Journal:  Hepatol Int       Date:  2013-11-19       Impact factor: 6.047

4.  Alterations in the Liver Fat Fraction Features Examined by Magnetic Resonance Imaging Following Bariatric Surgery: a Self-Controlled Observational Study.

Authors:  Mengyi Li; Di Cao; Yang Liu; Lan Jin; Na Zeng; Lixue Wang; Kaixin Zhao; Han Lv; Meng Zhang; Peng Zhang; Zhenghan Yang; Zhongtao Zhang
Journal:  Obes Surg       Date:  2020-05       Impact factor: 4.129

Review 5.  Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments.

Authors:  Akira Sasaki; Hiroyuki Nitta; Koki Otsuka; Akira Umemura; Shigeaki Baba; Toru Obuchi; Go Wakabayashi
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-27       Impact factor: 5.555

6.  A computer model simulating human glucose absorption and metabolism in health and metabolic disease states.

Authors:  Richard J Naftalin
Journal:  F1000Res       Date:  2016-04-12

7.  Sitagliptin Is More Effective Than Gliclazide in Preventing  Pro-Fibrotic and Pro-Inflammatory Changes in a Rodent Model of Diet-Induced Non-Alcoholic Fatty Liver Disease.

Authors:  Jing Ren; Xiaoyu Wang; Christine Yee; Mark D Gorrell; Susan V McLennan; Stephen M Twigg
Journal:  Molecules       Date:  2022-01-22       Impact factor: 4.411

8.  Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs.

Authors:  Fiona M Keane; Tsun-Wen Yao; Stefanie Seelk; Margaret G Gall; Sumaiya Chowdhury; Sarah E Poplawski; Jack H Lai; Youhua Li; Wengen Wu; Penny Farrell; Ana Julia Vieira de Ribeiro; Brenna Osborne; Denise M T Yu; Devanshi Seth; Khairunnessa Rahman; Paul Haber; A Kemal Topaloglu; Chuanmin Wang; Sally Thomson; Annemarie Hennessy; John Prins; Stephen M Twigg; Susan V McLennan; Geoffrey W McCaughan; William W Bachovchin; Mark D Gorrell
Journal:  FEBS Open Bio       Date:  2013-12-08       Impact factor: 2.693

9.  Liraglutide Inhibits Hepatitis C Virus Replication Through an AMP Activated Protein Kinase Dependent Mechanism.

Authors:  Mei-Yueh Lee; Wei-Chun Chen; Wei-Hao Hsu; Szu-Chia Chen; Jin-Ching Lee
Journal:  Int J Mol Sci       Date:  2019-09-14       Impact factor: 5.923

10.  The Role of GLP1 in Rat Steatotic and Non-Steatotic Liver Transplantation from Cardiocirculatory Death Donors.

Authors:  Cindy G Avalos-de León; Mónica B Jiménez-Castro; María Eugenia Cornide-Petronio; Araní Casillas-Ramírez; Carmen Peralta
Journal:  Cells       Date:  2019-12-09       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.